Month: May 2025

Press ReleaseNokia and Celesta Capital launch Astranu to advance healthcare imaging technologyStartup spin-out from Nokia Bell Labs will commercialize advanced healthcare imaging technology. Venture is the first in a Nokia – Celesta collaboration aiming to create a pipeline of spin outs from Nokia Bell Labs technologies. Astranu’s transformative technology delivers a highly performant, cost-effective imaging system for rapid and accurate 3D imaging of middle-ear conditions and hearing response.15 May 2025Murray Hill, New Jersey and San Mateo, California – Nokia and Celesta Capital today announced that Astranu, a company transforming hearing care through next-generation imaging technology, has officially spun out from Nokia as part of a collaboration to accelerate the commercialization of innovative technologies. This marks the inaugural...

Sodexo Inc., the US subsidiary of Sodexo S.A., announces today its intention to issue benchmark-sized US dollar-denominated note in one or more tranches, guaranteed by Sodexo S.A. (the “New Notes”), and a concurrent cash tender offer (the “Tender Offer”) for any and all of its existing 1.634% senior notes due 2026 (the “2026 Notes”). The Tender Offer is expected to expire at 5:00 pm, New-York City time, on May 22, 2025 unless extended or earlier terminated. Sodexo Inc. intends to prioritize, at its sole discretion, allocating the New Notes to holders of the 2026 Notes who indicate their firm intention to participate in the Tender Offer and wish to subscribe to the New Notes. The Tender Offer is subject to the successful completion of the issue of the New Notes, at Sodexo Inc.’s discretion. The purpose of the Tender Offer and the proposed...

30+ studies across diverse conditions illuminate the unique value of functional lung imaging with Xenon MRI DURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) — Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (“MRI”) of the lungs, will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit (RIS), taking place May 16–17 at the Marriott Marquis in San Francisco, California. Polarean will also attend the ATS 2025 International Conference from May 18–21, continuing its active engagement with leaders across pulmonary medicine. Polarean’s selection as a featured company at RIS 2025 underscores the growing recognition of the company’s Xenon MRI platform as an innovative tool for both...

VANCOUVER, Washington, May 15, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today shared the Company’s poster presented at the European Society for Medical Oncology’s (“ESMO”) Breast Cancer meeting on May 14-17, 2025, in Munich, Germany. A copy of the poster is available at the following link: ESMO Poster May 2025 More information about the data CytoDyn presented at ESMO suggesting the novel mechanism of action of leronlimab for the treatment of solid tumors can be found in the Company’s press release issued on May 13, 2025. About CytoDyn CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab,...